| Briumvi |
761238 |
001 |
351(a) |
ublituximab-xiiy |
Injection |
Intravenous |
150MG/6ML (25MG/ML) |
Single-Dose Vial |
2022/12/28
|
TG Therapeutics, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Lunsumio |
761263 |
001 |
351(a) |
mosunetuzumab-axgb |
Injection |
Intravenous |
1MG/ML |
Single-Dose Vial |
2022/12/22
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Lunsumio |
761263 |
002 |
351(a) |
mosunetuzumab-axgb |
Injection |
Intravenous |
30MG/30ML (1MG/ML) |
Single-Dose Vial |
2022/12/22
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Adstiladrin |
125700 |
001 |
351(a) |
nadofaragene firadenovec-vncg |
For Suspension |
Intravesical |
3x10^11 viral particles (vp)/mL |
Single-Dose Vial |
2022/12/16
|
Ferring Pharmaceuticals A/S |
Rx |
Licensed |
N/A |
N/A |
| Idacio |
761255 |
001 |
351(k) Biosimilar |
adalimumab-aacf |
Injection |
Subcutaneous |
40MG/0.8ML |
Autoinjector |
2022/12/13
|
Fresenius Kabi USA, LLC |
Rx |
Licensed |
adalimumab |
Humira |
| Idacio |
761255 |
002 |
351(k) Biosimilar |
adalimumab-aacf |
Injection |
Subcutaneous |
40MG/0.8ML |
Pre-Filled Syringe |
2022/12/13
|
Fresenius Kabi USA, LLC |
Rx |
Licensed |
adalimumab |
Humira |
| Rebyota |
125739 |
001 |
351(a) |
fecal microbiota, live-jslm |
Suspension |
Rectal |
BETWEEN 1X10^8 AND 5X10^10CFU |
Single-Use Bottle |
2022/11/30
|
Ferring Pharmaceuticals Inc. |
Rx |
Licensed |
N/A |
N/A |
| Albutein |
102478 |
009 |
351(a) |
Albumin (Human) |
Injection |
Intravenous |
5G/100ML |
Bag |
2022/11/29
|
Grifols Biologicals LLC |
Disc |
Licensed |
N/A |
N/A |
| Hemgenix |
125772 |
001 |
351(a) |
etranacogene dezaparvovec-drlb |
Injection |
Intravenous |
1X10E13GENOME COPIES/ML |
Single-Dose Vial |
2022/11/22
|
CSL Behring LLC |
Rx |
Licensed |
N/A |
N/A |
| Tzield |
761183 |
001 |
351(a) |
teplizumab-mzwv |
Injection |
Intravenous |
2MG/2ML (1MG/ML) |
Single-Dose Vial |
2022/11/17
|
Provention Bio, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Elahere |
761310 |
001 |
351(a) |
mirvetuximab soravtansine-gynx |
Injection |
Intravenous |
100MG/20ML (5MG/ML) |
Single-Dose Vial |
2022/11/14
|
ImmunoGen, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Erelzi |
761042 |
004 |
351(k) Biosimilar |
etanercept-szzs |
For Injection |
Subcutaneous |
25MG |
Multi-Dose Vial |
2022/11/10
|
Sandoz Inc. |
Disc |
Licensed |
etanercept |
Enbrel |
| Rotarix |
125265 |
002 |
351(a) |
Rotavirus Vaccine, Live, Oral |
Suspension |
Oral |
106.0CCID50 |
Tube |
2022/11/04
|
GlaxoSmithKline Biologicals |
Disc |
Licensed |
|
|
| Rotarix |
125265 |
003 |
351(a) |
Rotavirus Vaccine, Live, Oral |
Suspension |
Oral |
106.0CCID50 |
Oral Applicator |
2022/11/04
|
GlaxoSmithKline Biologicals |
Rx |
Licensed |
|
|
| Tecvayli |
761291 |
001 |
351(a) |
teclistamab-cqyv |
Injection |
Subcutaneous |
30MG/3ML (10MG/ML) |
Single-Dose Vial |
2022/10/25
|
Janssen Biotech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Tecvayli |
761291 |
002 |
351(a) |
teclistamab-cqyv |
Injection |
Subcutaneous |
153MG/1.7ML (90MG/ML) |
Single-Dose Vial |
2022/10/25
|
Janssen Biotech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Imjudo |
761289 |
001 |
351(a) |
tremelimumab-actl |
Injection |
Intravenous |
25MG/1.25ML (20MG/ML) |
Single-Dose Vial |
2022/10/21
|
AstraZeneca AB |
Rx |
Licensed |
N/A |
N/A |
| Imjudo |
761289 |
002 |
351(a) |
tremelimumab-actl |
Injection |
Intravenous |
300MG/15ML (20MG/ML) |
Single-Dose Vial |
2022/10/21
|
AstraZeneca AB |
Rx |
Licensed |
N/A |
N/A |
| Menveo |
125300 |
002 |
351(a) |
Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine |
Injection |
Intramuscular |
0.5ML |
Single-Dose Vial |
2022/10/14
|
GlaxoSmithKline Biologicals |
Rx |
Licensed |
|
N/A |
| Vegzelma |
761268 |
001 |
351(k) Biosimilar |
bevacizumab-adcd |
Injection |
Intravenous |
100MG/4ML (25MG/ML) |
Single-Dose Vial |
2022/09/27
|
CELLTRION, Inc. |
Rx |
Licensed |
bevacizumab |
Avastin |